ABOUT US: Scientific Advisory Board

The Scientific Advisory Board (SAB) of the Foundation reads as a Who's Who of CLL research. The SAB ensures that the clinical and scientific aspects of the research are of the highest order of integrity and originality. They provide oversight to ensure the research is conducted with the highest ethical standard. The Scientific Advisory Board oversees the development and implementation of the submission, evaluation, and funding processes for clinical research proposals.

Federico Caligaris-Cappio, M.D.
Instituto Scientifico San Raffaele
Milan, Italy

Carlo Croce, M.D.
The Ohio State University Comprehensive Cancer Center
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Thomas Kipps, M.D.
University of California, San Diego
Rebecca and John Moores Cancer Center

Raymond Meyn, Ph.D.
University of Texas M.D. Anderson Cancer Center

Susan O'Brien, M.D.
University of Texas M.D. Anderson Cancer Center

William Plunkett, Ph.D.
University of Texas M.D. Anderson Cancer Center

Kanti Rai, M.D.
Long Island Jewish Medical Center

Steven Rosen, M.D.
Robert H. Lurie Comprehensive Cancer Center
Northwestern University (Chicago)

Neil Kay, M.D.
Mayo Clinic

Daniel Catovsky, M.D., DSc Emeritus Professor
Section of Hemato-Oncology
Institute of Cancer Research, UK

Michael Keating, M.B., B.S. (Ad Hoc)
University of Texas M.D. Anderson Cancer Center